Location History:
- Suita, JP (2017 - 2021)
- Osaka, JP (2017 - 2024)
Company Filing History:
11 out of 987 
4 out of 2,316 
2 out of 575 
Years Active: 2017-2025
Title: The Innovative Journey of Shigeru Miyagawa
Introduction: Shigeru Miyagawa, a prominent inventor based in Osaka, Japan, has made significant contributions to the fields of medicine and biotechnology. With a portfolio of 13 patents, his innovative research has focused on developing methods and materials that improve patient outcomes, particularly in the realm of heart disease treatment.
Latest Patents: Among his latest patents, Shigeru Miyagawa has developed a "Method for producing fibrin sheet," which allows for the creation of a fibrin sheet containing a selection of cells and drugs in a fibrin gel. This method enhances the potential for targeted therapies. Another noteworthy patent is the "Transplant material for treatment of heart disease." This invention highlights a groundbreaking discovery that a cell cluster obtained from isolated cells, which adhere to each other, can secrete adiponectin after being transplanted into the heart, demonstrating excellent therapeutic effects for heart disease.
Career Highlights: Shigeru Miyagawa has been associated with esteemed institutions such as Osaka University, where he has engaged in innovative research, as well as Terumo Corporation, which specializes in medical devices. His work has contributed to advancements in cardiac treatment technologies.
Collaborations: Throughout his career, Miyagawa has collaborated with notable professionals in his field, including Yoshiki Sawa and Atsuhiro Saito. These partnerships have further reinforced his impact on medical research and innovation.
Conclusion: Shigeru Miyagawa's contributions to the medical field through his inventions and patents underscore the importance of innovation in improving healthcare. His work continues to inspire future advancements, paving the way for enhanced treatments and technologies in the medical industry.